Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What You Need To Know Ahead of Boston Scientific's Earnings Release

With a market cap of $144.2 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets innovative medical devices used in various interventional medical specialties worldwide. It operates through two main segments: MedSurg and Cardiovascular, offering advanced solutions for diagnosing and treating complex conditions across gastrointestinal, urological, neurological, and cardiovascular care.

The Marlborough, Massachusetts-based company is slated to announce its fiscal Q3 2025 earnings results before the market opens on Wednesday, Oct. 22. Ahead of the event, analysts expect Boston Scientific to report an adjusted EPS of $0.71, up 12.7% from $0.63 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarterly reports.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.